C.B. Dollaway, a veteran fighter from the UFC, was suspended for two years by USADA after being tested positive for several banned substances.
USADA (US Anti-Doping Agency) officials announced the news on Monday after Dollaway was punished in accordance with the UFC's anti-doping policy.
"Dollaway, 35, was tested positive for anastrozole, growth hormone-releasing peptide 2 (GHRP-2 or pralmorelin), a metabolite of GHRP-2 and GHRP-6 at the Following an out-of-competition urine sample that he provided in December. 19, 2018. Anastrozole is a specified substance belonging to the class of hormonal and metabolic modulators, while GHRP-2 and GHRP-6 are specified substances belonging to the class of peptide hormones, growth factors, related substances and mimetics.
"Dollaway has also been tested positive for clomiphene in an out-of-competition urine sample taken on February 9, 2019."
Anastrozole is generally used as a treatment for women with breast cancer, but it can be used in men to reduce the amount of estrogen produced in the body, which can be a side effect of the use of other drugs such as steroids or testosterone.
GHRP-2 or pralmorelin is a synthetically produced growth hormone, which can be used to increase endurance as well as many other performance enhancing benefits.
Clomiphene has become a common medication found in many unsuccessful tests with former UFC athletes, including Brock Lesnar and Jon Jones. Clomiphene is another drug commonly used by women, but it can also be used to increase testosterone production in men.
Dollaway was also eliminated for using an IV above the limit allowed by athletes participating in the UFC.
"Dollaway received an IV infusion out of bounds on December 13, 2018," officials at USADA said. "IV infusions and / or injections of more than 100 ml per 12-hour period are prohibited, with the exception of those that are legitimately received during hospital treatment, surgery or surgery. clinical diagnostic investigations. "
Although Dollaway failed several tests during a given period, the USADA finally based its suspension on the date of the initial failure, which kicked off its period of time. ; ineligibility.
"Dollaway's two positive tests and the use of an IV above the limit were treated as a first violation because after a thorough investigation, it was determined that the positive tests were consistent with ingestion prior to January 11th. 2019, he received notification of his first positive test, "said officials from USADA. "Dollaway's two-year suspension period began on December 13, 2018."
This means that Dolloway will not be eligible to return to the game until December 13, 2020.
Dolloway has not participated in the competition since September 2018, after losing to Khalid Murazaliev in Russia's TKO, ending his two-game winning streak. Now, he will have to stay away until the end of 2020, when he will be allowed to compete again.
Following the announcement of his suspension, Dollaway issued a statement stating that he had never consciously ingested any of the prohibited substances mentioned in his drug testing.
"In light of USADA's recent decision to sentence me to two years, I want it to be clear that I did not knowingly or intentionally take any performance-enhancing medication. Dollaway wrote on Instagram. "As many people close to me know, I suffered a serious back injury in 2016. My insurance being complete, I had to find an alternative if I wanted to continue to compete in the martial arts. mixed.
"I traveled to Mexico to undergo a stem cell procedure and eventually came into contact with the substances mentioned. I'm sorry to drop my friends, family and fans. I would like to personally thank Donna Marcolini, Vice President of Health and Performance for the UFC, for her help and for believing in me. I will take advantage of this time to continue working on my health and, hopefully, be ready to return in 2020 as a healthy athlete / fighter for the first time since 2016. "
The back injury evoked by Dollaway took place in 2016 while he was involved in a lift accident with several other fighters competing at the UFC 203 in Cleveland. Dollaway later stated that he had suffered permanent damages and he had subsequently filed a lawsuit.